PNC Financial Services Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

PNC Financial Services Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-608	Closed	-$11K	–	4857
2022 Q1	$11K	Sell	608 -1,415	-70%	-$25.5K	﹤0.01%	3812
2021 Q4	$43K	Buy	+2,023	New	+$39.9K	﹤0.01%	3194

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PNC Financial Services Group's OCDX Position: Q2 2022 in Review

PNC Financial Services Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 608 shares — an estimated $11K sold.

PNC Financial Services Group first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $43K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

PNC Financial Services Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
PNC Financial Services Group sold 608 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $11K.
PNC Financial Services Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
PNC Financial Services Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $43K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on PNC Financial Services Group's 13F filing for Q2 2022, filed 12 Aug 2022.